Minimally Residual of Esophageal Cancer 001 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Minimally Residual of Esophageal Cancer 001 — Stella

Recruiting

Back to Esophageal Carcinoma trials

Trial locations(1 site)

China

Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei

Key details

Sponsor

Hebei Medical University Fourth Hospital

Enrollment target

~56 participants

Started

February 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated July 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov